3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Ipilimumab
6
pembrolizumab
5
Nivolumab
5
Dacarbazine
5
CTLA-4 Antigen
4
Carboplatin
3
Bevacizumab
3
relatlimab
2
aflibercept
2
Temozolomide
2
Ranibizumab
2
Radiosurgery
2
Paclitaxel
2
Lenalidomide
2
Immunoglobulin G
2
Embolization, Therapeutic
2
Disulfides
2
Cyclophosphamide
2
Colony-Stimulating Factors
2
Albumin-Bound Paclitaxel
2
AZD 6244
2
130-nm albumin-bound paclitaxel
2
utomilumab
1
ulixertinib
1
trametinib
1
tebentafusp
1
sotrastaurin
1
sargramostim
1
poly ICLC
1
pasireotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uveal Melanoma
×
cemiplimab
×
Clear all
No trials found.